| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $55.3M | -29.0% |
| R&D Expense | $181.1M | +12.0% |
| SG&A Expense | $40.5M | +9.9% |
| Operating Income | -$166.2M | -37.7% |
| Pre-tax Income | -$162.7M | -35.2% |
| Net Income | -$162.7M | -35.2% |
| EPS (Basic) | -$2.03 | -30.1% |
| EPS (Diluted) | -$2.03 | -30.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $73.5M | -51.6% |
| Short-term Investments | $198.0M | -7.7% |
| Current Assets | $288.9M | -23.8% |
| Total Assets | $307.4M | -23.6% |
| Current Liabilities | $47.8M | -22.0% |
| Total Liabilities | $47.8M | -28.3% |
| Stockholders' Equity | $259.6M | -22.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$144.4M | -97.2% |
| Investing Cash Flow | $14.3M | +120.0% |
| Financing Cash Flow | $54.2M | -63.8% |